Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Author(s) -
Sébastien L. Degorce,
Bernard Barlaam,
Elaine Cadogan,
Allan Dishington,
Richard Ducray,
Steven C. Glossop,
Lorraine Hassall,
Franck Lach,
Alan Pak Tao Lau,
Thomas M. McGuire,
Thorsten Nowak,
Gilles Ouvry,
Kurt G. Pike,
Andrew Thomason
Publication year - 2018
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/acs.jmedchem.8b00936
Subject(s) - chemistry , quinoline , bioavailability , pharmacology , kinase , orally active , drug discovery , ataxia , biochemistry , in vitro , neuroscience , organic chemistry , medicine , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom